DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer

Naoki Katase1, Kodai Kudo1,2, Kazuhiro Ogawa1,2

  • 1Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Oral Diseases
|June 16, 2022
PubMed
Abstract

Insights

The dickkopf WNT signaling inhibitor 3 (DKK3) and cytoskeleton associated protein 4 (CKAP4) axis promotes oral squamous cell carcinoma (OSCC) progression. Targeting this DKK3/CKAP4 pathway with antibodies offers a potential therapeutic strategy for OSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Dickkopf WNT signaling inhibitor 3 (DKK3) modulates oral squamous cell carcinoma (OSCC) malignancy by activating Akt.
  • Cytoskeleton associated protein 4 (CKAP4) acts as a DKK3 receptor, activating Akt in esophageal cancer, but its role in OSCC was unknown.

Purpose of the Study:

  • To investigate the expression and clinical significance of DKK3 and CKAP4 in OSCC.
  • To evaluate the potential of anti-DKK3 and anti-CKAP4 antibodies as therapeutic agents against OSCC.

Main Methods:

  • DKK3 and CKAP4 protein expression was analyzed in OSCC tissues.
  • Correlation between protein expression and clinical data was assessed.
  • The effect of anti-DKK3 and anti-CKAP4 antibodies on cancer cell behavior was examined.

Main Results:

  • DKK3 and CKAP4 were frequently expressed in OSCC and correlated with advanced T-stage and TNM stage.
  • DKK3 and CKAP4 served as independent prognostic biomarkers for overall survival and disease-free survival, respectively.
  • DKK3/CKAP4 double-negative status indicated a favorable prognosis, while antibodies against DKK3/CKAP4 inhibited cancer cell proliferation, migration, and invasion.

Conclusions:

  • The DKK3/CKAP4 axis plays a crucial role in OSCC progression.
  • Targeting the DKK3/CKAP4 pathway presents a promising therapeutic strategy for OSCC treatment.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
444
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K